Skip to main content
OpenTrials
Completed

NCT Number: NCT02085681

Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases

The aim of this study is to compare the effectiveness of identifying diabetic retinopathy using tele-medicine based Digital Retinal Imaging in Diabetes Clinics with that of the conventional referral system.

Hypothesis: Tele-medicine based digital retinal imaging involving a diabetes centre will identify proportionately more diabetic patients with DR and lead to higher acceptance rate with subsequent ophthalmic referral and management

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aravind Eye Hospital

Madurai, Tamil Nadu, 625020, India

About this study

The design is a cluster randomized trial of tele-medicine versus usual care in diabetic patients. The primary outcome of the study is the proportion of patients with confirmed DR at Aravind Eye Hospital (AEH). DR will be graded using the International Clinical Diabetic Retinopathy Disease Severity Scale. A sample size of 616 patients in both arms is required to detect a risk ratio of 1.8 or above at 90% power, 1% alpha and a design effect of 2. Eight clinics will be recruited and equally randomized to tele-medicine or usual care stratified by distance from AEH. Inclusion criteria include a confirmed diagnosis of diabetes, age over 50, no retinal exam in the previous year. In the tele-medicine arm patients will be offered fundus imaging and patients diagnosed with DR or probable DR will be counselled to visit AEH to confirm DR. In the usual care arm, the eligible patients will be counselled and referred to undergo an eye examination at AEH. In both the arms the counselling and the awareness creation materials will be standardized. Fundus imaging will be offered at the end of the study to those who refuse initially and all those in the usual arm who did not attend AEH.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetic patients (as per ICD-9 code 250) in the age group of ≥50 years

Exclusion criteria

  • Patients <50 years of age
  • Already enrolled as study patients at the diabetes centre
  • Patients screened for DR in free camps organized by the diabetes centre
  • Diabetic patients who underwent retinal examination in the previous year prior to this intervention
  • Patients with disability (physical or mental) who have difficulty in travelling to the eye hospital

Treatment and study plan

Tele-medicine

Other

Patients at the diabetes clinics will be subjected to non-mydriatic retinal imaging and the images will be transferred to the eye hospital via internet using a specified software - Aravind Diabetic Retinopathy Evaluation Software (ADRES) that enables a retinal specialist to read and grad the image and send the feedback immediately to the diabetes clinic. Based on the presence or absence of DR the patients will be referred to the eye hospital for detailed retinal examination.

Other names: Tele-medicine aided retinal imaging

Conventional referral

Other

All eligible patients in the conventional arm will be counselled on the importance of eye screening and will be referred to the eye hospital

Primary outcomes

  1. Proportion of patients with confirmed Diabetic Retinopathy (DR) diagnosed at the eye hospital

    Time frame: 6 months

    Out of the patients referred from the diabetes clinics to the eye hospital, the number of patients with confirmed DR will be measured. This proportion will be compared between the two arms.

Secondary outcomes

  1. The severity of diabetic retinopathy (DR)

    Time frame: 6 months

    Among patients confirmed with DR, the severity of the disease will be measured using standard classification (Diabetic Retinopathy Disease Severity Scale) approved by the American Academy of Ophthalmology

  2. The acceptance rate for referral in each arm

    Time frame: 6 months

    Out of the patients referred from the diabetes clinic, the number of patients actually reported to the eye hospital will be measured.

  3. Proportion of patients eligible for referral who had DR and who did not attend

    Time frame: 6 months

    Patients who are referred by not attended to the eye hospital will be followed up and examined to find out what proportion of them actually as DR

Other outcomes

  1. Barriers to compliance

    Time frame: 6 months

    Patients will be interviewed to identify the barriers to compliance following the referral

  2. Drivers of acceptance

    Time frame: 6 months

    Patients will be interviewed to identify the factors that encouraged them to visit the eye hospital following referral

Sponsors and collaborators

Lead sponsor

Aravind Eye Care System

Other

Collaborators

  • London School of Hygiene and Tropical Medicine

Registry information

Official study title

Effectiveness of Tele-medicine in Identifying Diabetic Retinopathy Cases Attending Diabetologists' Clinics Compared to the Conventional Referral System

Acronym: DRTM

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Mar 13, 2014
Registry last updated
Apr 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.